A Preliminary Test of an mHealth Facilitated Health Coaching Intervention to Improve Medication Adherence among Persons Living with HIV

被引:9
作者
Ramsey, Susan E. [1 ,2 ,3 ]
Ames, Evan G. [3 ]
Uber, Julia [3 ]
Habib, Samia [3 ]
Clark, Seth [1 ,2 ,3 ]
Waldrop, Drenna [4 ]
机构
[1] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Rhode Isl Hosp, Div Gen Internal Med, 593 Eddy St, Providence, RI 02903 USA
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
HIV; Medication Adherence; mHealth Intervention; Health Coaching; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; DEPRESSION CBT-AD; LOW-LEVEL VIREMIA; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; SELF-REPORT; DRUG-USERS; REMINDERS; OUTCOMES;
D O I
10.1007/s10461-021-03342-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study examined feasibility, acceptability, and preliminary efficacy of an mHealth facilitated health coaching antiretroviral therapy (ART) adherence intervention. Persons living with HIV (n = 53) were randomized to an in-person adherence session and 12 months of app access and health coaching via the app (Fitbit Plus) versus single adherence session (SOC). At baseline and 1, 3, 6, and 12 months, we measured ART adherence, substance use, and depressive symptoms. We also conducted individual qualitative interviews. The intervention was found to be largely feasible and highly acceptable, with the health coach spending an average of 2.4 min per month with a participant and 76.5% of Fitbit Plus participants using the app regularly at 12 months. While most comparisons were not significant, the pattern of results was consistent with better adherence in the Fitbit Plus compared to SOC condition. Substance use was significantly associated with poorer ART adherence while depressive symptoms were not. ClinicalTrials.gov Identifier: NCT02676128; Registered: 2/8/2016.
引用
收藏
页码:3782 / 3797
页数:16
相关论文
共 69 条
[1]  
Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041
[2]  
[Anonymous], 2020, HIV SURVEILLANCE S, P25
[3]  
[Anonymous], 1999, COGN BEHAV PRACT, DOI DOI 10.1016/S1077-7229(99)80052-2
[4]   Preventing HIV antiretroviral resistance through better monitoring of treatment adherence [J].
Bangsberg, David R. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 :S272-S278
[5]   Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study [J].
Bavinton, Benjamin R. ;
Pinto, Angie N. ;
Phanuphak, Nittaya ;
Grinsztejn, Beatriz ;
Prestage, Garrett P. ;
Zablotska-Manos, Iryna B. ;
Jin, Fengyi ;
Fairley, Christopher K. ;
Moore, Richard ;
Roth, Norman ;
Bloch, Mark ;
Pell, Catherine ;
McNulty, Anna M. ;
Baker, David ;
Hoy, Jennifer ;
Tee, Ban Kiem ;
Templeton, David J. ;
Cooper, David A. ;
Emery, Sean ;
Kelleher, Anthony ;
Grulich, Andrew E. .
LANCET HIV, 2018, 5 (08) :E438-E447
[6]  
Beer L, 2020, AIDS
[7]   Adherence to Antiretroviral Therapy and Virologic Failure A Meta-Analysis [J].
Bezabhe, Woldesellassie M. ;
Chalmers, Leanne ;
Bereznicki, Luke R. ;
Peterson, Gregory M. .
MEDICINE, 2016, 95 (15)
[8]   Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study [J].
Boillat-Blanco, Noemie ;
Darling, Katharine E. A. ;
Schoni-Affolter, Franziska ;
Vuichard, Danielle ;
Rougemont, Mathieu ;
Fulchini, Rosamaria ;
Bernasconi, Enos ;
Aouri, Manel ;
Clerc, Olivier ;
Furrer, Hansjakob ;
Gunthard, Huldrych F. ;
Cavassini, Matthias .
ANTIVIRAL THERAPY, 2015, 20 (02) :165-175
[9]   A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care [J].
Braithwaite, RS ;
McGinnis, KA ;
Conigliaro, J ;
Maisto, SA ;
Crystal, S ;
Day, N ;
Cook, RL ;
Gordon, A ;
Gordon, A ;
Bridges, MW ;
Seiler, JFS ;
Justice, AC .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (07) :1190-1197
[10]  
Centers for Disease Control and Prevention, 2019, HIV Surveillance Supplemental Report